Form 4 for TMDX TransMedics Group, Inc.
Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-15 · accession 0000899243-21-036415 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-17 | 2021-09-15 | TMDX | Provost Miriam | VP of US Regulatory, FDA Rel | M - OptEx | $16.14 | +5,625 | 12.4K | +83% | +$90.8K |
| D | 2021-09-17 | 2021-09-15 | TMDX | Provost Miriam | VP of US Regulatory, FDA Rel | S - Sale+OE | $31.34 | -3,877 | 8,554 | -31% | -$121.5K |
| D | 2021-09-17 | 2021-09-15 | TMDX | Provost Miriam | VP of US Regulatory, FDA Rel | M - OptEx | $0.00 | -5,625 | 9,375 | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-15 | M | A | 5,625 | $16.14 | 12,431 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-15 | S | D | 3,877 | $31.34 | 8,554 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-15 | M | D | 5,625 | $0.00 | 9,375 | D | $16.14 · — to 2030-02-27 | 5,625 Common Stock | (F2) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. |